Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

5.80
Delayed Data
As of Apr 29
 -0.17 / -2.85%
Today’s Change
4.75
Today|||52-Week Range
14.41
-26.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues4.4M4.9M90.7M9.1M
 
 
 
 
 
Depreciation And Amortization354.0K614.0K589.0K735.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses96.6M42.9M46.9M47.5M
 
 
 
 
 
Research And Development88.4M34.1M37.7M38.9M
 
 
 
 
 
Total Operating Expenses97.0M43.5M47.5M48.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-92.6M-38.6M43.3M-39.2M
 
 
 
 
 
Interest Expense On Debt647.0K99.0K311.0K310.0K
 
 
 
 
 
Other Expenses-40.0K263.0K75.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-93.3M-38.4M43.0M-39.3M
 
 
 
 
 
Income Taxes0.000.00-480.0K-145.0K
 
 
 
Net Income-93.3M-38.4M41.7M-39.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.9M49.1M49.2M49.2M
 
 
 
 
 
Shares To Calculate EPS Diluted48.9M49.1M49.8M49.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.91-$0.78$0.84-$0.80
 
 
 
 
 
EPS Diluted-$1.91-$0.78$0.84-$0.80